Global health advocates gathered at the AIDS 2026 conference in Rio de Janeiro, Brazil, issued a stark warning to world leaders: despite historic strides in curbing pediatric HIV, thousands of children are still falling through the cracks of global healthcare systems. Experts emphasized that every child living with HIV who lacks access to care or antiretroviral therapy represents a health infrastructure in desperate need of urgent rebuilding.
Dr. Doris K. Macharia, President of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), cautioned that global health leaders cannot allow funding drops or system gaps to turn back the clock on pediatric health. While global figures show significant progress down to roughly 1.3 million children living with HIV in 2025 from 2.6 million a decade earlier a persistent and dangerous treatment gap threatens to undo decades of hard-won momentum.
The stark disparity between adult and pediatric healthcare outcomes remains one of the most pressing challenges in global health today. Currently, only about 55 percent of children living with HIV are receiving lifesaving antiretroviral treatment, compared to roughly 78 percent of adults. While successful Prevention of Mother-to-Child Transmission (PMTCT) programs have largely driven down overall new infections, closing this pediatric treatment gap is mandatory if the international community hopes to achieve its target of zero new childhood HIV infections worldwide.
In sub-Saharan Africa, local leadership and community-driven initiatives offer a blueprint for bridging this divide. In Kenya, specialized organizations operating since 2000 have partnered with the Ministry of Health and local bodies to fortify prevention, care, and treatment networks, particularly across high-burden regions like Homa Bay County. By empowering community health workers, driving local skills transfer, and utilizing data-driven tracking, these regional programs have proven remarkably resilient.
Despite severe funding cuts and resource reductions in recent years that disproportionately threaten vulnerable mothers and infants, countries such as Kenya, Uganda, Tanzania, Mozambique, and Zambia have managed to push PMTCT coverage past 90 percent, noticeably outperforming the global average of 87 percent.
However, clinical experts caution that achieving high coverage during pregnancy is only half the battle, as the postpartum and breastfeeding periods remain critical vulnerability windows. While pregnant women maintain frequent contact with healthcare facilities through routine antenatal care, health system engagement often drops sharply after delivery.
Mothers face compounding socioeconomic challenges, including heavy household responsibilities, pervasive food insecurity, and the high cost or sheer physical distance of traveling to clinical facilities. Consequently, some mothers default on their antiretroviral regimens, drastically increasing the risk of vertical transmission to their infants during breastfeeding.
To overcome these structural hurdles, health systems must evolve beyond traditional perinatal care to support mothers well past delivery, while simultaneously expanding HIV prevention strategies for women who test negative during pregnancy. Transforming this landscape depends heavily on new medical innovations, such as the rollout of long-acting injectable pre-exposure prophylaxis (PrEP), including groundbreaking options like lenacapavir showcased at AIDS 2026. These long-acting formulations offer continuous, hassle-free protection for pregnant and breastfeeding women, drastically lowering acquisition risks and safeguarding babies.
With the science and clinical tools to end pediatric HIV already in hand, Dr. Macharia and fellow advocates are urging governments and global partners to secure the necessary funding, rebuild fragile health systems, and fulfill the promise of an AIDS-free generation.
